Beta-thromboblogulin lowered by dipyridamole in diabetes

Factors influencing safe glucose-lowering in older adults with type 2 diabetes: A PeRsOn-centred ApproaCh To IndiVidualisEd (PROACTIVE) Glycemic Goals for older people: A position statement of Primary Care Diabetes Europe.

Primary care diabetes·2019

Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - Feasibility testing, pilot randomised controlled trial and mixed methods process evaluation.

International journal of nursing studies·2017

Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013.

Diabetic medicine : a journal of the British Diabetic Association·2017

Glucose-lowering therapy in type 2 diabetes. New hope after the EMPA-REG outcome trial.

Herz·2016

Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013.

Diabetes, obesity & metabolism·2016

Secreted Frizzled-Related Protein 4 (SFRP4) is Elevated in Patients with Diabetes Mellitus.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2016

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Secreted nuclease effector neutralization by active site mimicry in Bacillota.

mBio·2026

Single-cell morphological responses as predictors of ciprofloxacin resistance in Acinetobacter baumannii.

Microbiology spectrum·2026

In Vitro Activity of Ceftazidime/Avibactam Against Multidrug-Resistant Gram-Negative Bacilli in Niger.

Nigerian medical journal : journal of the Nigeria Medical Association·2026

BileActome reveals community-assembled bile acid metabolism in the rumen microbiome.

ISME communications·2026

The miR-424-3p/PIP5K1C axis regulates AKT phosphorylation and granulosa cell proliferation.

Cellular signalling·2026

Synthetic microbial communities: emerging live biotherapeutics for targeted gut microbiome modulation.

Gut microbes·2026

Related Experiment Videos

Beta-thromboblogulin lowered by dipyridamole in diabetes

Related Concept Videos

Factors influencing safe glucose-lowering in older adults with type 2 diabetes: A PeRsOn-centred ApproaCh To IndiVidualisEd (PROACTIVE) Glycemic Goals for older people: A position statement of Primary Care Diabetes Europe.

Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - Feasibility testing, pilot randomised controlled trial and mixed methods process evaluation.

Prevalence, glucose control and relative survival of people with Type 2 diabetes in the UK from 1991 to 2013.

Glucose-lowering therapy in type 2 diabetes. New hope after the EMPA-REG outcome trial.

Secular trends in antihyperglycaemic medication prescriptions in older adults with diabetes and chronic kidney disease: 2004-2013.

Secreted Frizzled-Related Protein 4 (SFRP4) is Elevated in Patients with Diabetes Mellitus.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Secreted nuclease effector neutralization by active site mimicry in Bacillota.

Single-cell morphological responses as predictors of ciprofloxacin resistance in Acinetobacter baumannii.

In Vitro Activity of Ceftazidime/Avibactam Against Multidrug-Resistant Gram-Negative Bacilli in Niger.

BileActome reveals community-assembled bile acid metabolism in the rumen microbiome.

The miR-424-3p/PIP5K1C axis regulates AKT phosphorylation and granulosa cell proliferation.

Synthetic microbial communities: emerging live biotherapeutics for targeted gut microbiome modulation.

Related Experiment Videos

Beta-thromboblogulin lowered by dipyridamole in diabetes

Related Concept Videos

Related Articles